Clinical trial

Consolidation Serplulimab Following Concurrent Chemoradiotherapy for LS-SCLC Patients

NCT05443646

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2022-09-23

PhasePHASE2

Study timeline

Study start (actual)2022-09-23Date precision: day

Registry last updated2024-05-07

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Limited Stage Small Cell Lung Cancerunresolved

Interventions

HLX10DRUG

hypofractionated radiotherapyRADIATION

Prophylactic Cranial Irradiation (PCI)RADIATION

Sponsors & collaborators

Cancer Institute and Hospital, Chinese Academy of Medical Scienceslead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05443646 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.